ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres® Y-90 resin microspheres in China from the National Medical Products Administration
February 11, 2022Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today with its shareholder, Grand Pharmaceutical Group Limited, that SIR-Spheres® Y-90 resin microspheres... -
Sirtex Medical announces new SIR-Spheres(R) DOORwaY-90 Study: The first prospective multicenter U.S.-based trial for registration as first-line treatment for hepatocellular carcinoma
March 23, 2021Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, announced full FDA approval of the DOORwaY90 Study, a trial evaluating the safety and efficacy of selective internal radiation therapy (SIRT) using SIR-Spheres® Y-90 resin ... -
Sirtex Medical appoints Kevin R. Smith as Chief Executive Officer
October 17, 2019Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, announced the appointment of Kevin R. Smith as Chief Executive Officer of Sirtex Medical Pty Ltd.
Pharma Sources Insight January 2025
